Individuals using tirzepatide may experience more common stomach pain, nausea, vomiting, or diarrhea
Age-Related Decline: As our dogs age, they might become less energetic and may experience mobility issues
75.4%) compared to the DPP-4i group, although these differences were below the minimum SMD threshold of 0.2
This sufficiently powered clinical study did not find a beneficial effect of linagliptin versus placebo on albuminuria in patients with T2DM, although exploratory analyses indicated more responders and fewer non-responders in terms of UACR in the linagliptin group
Injection site reactions, persistent heartburn, and severe constipation affect a subset of tirzepatide users disproportionately
Effect of semaglutide on menopausal symptoms: A randomized controlled trial